We welcome Pooja et al's comments1 on our multinational study from Latin America, which reported high rates of antibiotic prescriptions for children with COVID-19 or multisystem inflammatory syndrome in children.2 They reinforce our findings by describing their experience in a UK centre, reporting that 390/607 (64.3%) children received antibiotics, which was strikingly higher than our study (24.5%). Importantly, 315/390 (80.7%) children received broad-spectrum antibiotics.1.
Tackling antibiotic resistance during the COVID‐19 pandemic is a new challenge for paediatricians